Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.
Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.
New findings about a developmental step in the lifecycle of malaria parasites may help scientists develop new ways to prevent the disease from spreading.
Using low-frequency radio waves to send blood pressure data, a group of students has provided a proof of concept that could enable in-home health care for people without cellular or broadband access.
Mental health crises among children and adolescents requiring emergency department care skyrocketed during the pandemic and have stayed elevated despite a return to normalcy, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Our 11th episode features Stephanie Wisner ’16, co-founder of Centivax, a therapeutics company that’s creating universal vaccines to reduce and eradicate the remaining complex pathogens of the 21st century.
A clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found remaining on the anti-obesity drug tirzepatide promoted additional weight loss and preserved improvements in metabolic and cardiovascular health.
An intercampus collaboration that aims to provide digital health care tools to pregnant refugee women, who are at elevated risk for pregnancy complications but often afraid to seek medical care, has been awarded a National Academy of Medicine Catalyst Prize.
A preclinical study by Weill Cornell Medicine investigators shows that a specific human genetic variant of a receptor that stimulates insulin release may help individuals be more resistant to obesity.